Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02926339 · ClinicalTrials.gov registry record · NA

Teens Against Tobacco Use: A Tobacco Prevention Curriculum and Advocacy Initiative

A NA study, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
639
Enrollment target

NCT02926339: Completed NA study, sponsored by The University of Texas Health Science Center, Houston.

NCT02926339 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 639 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (54% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02926339, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
639 participants
Enrollment target

Study Summary

This study evaluates the efficacy of Teens Against Tobacco Use anti-tobacco presentations on tobacco use susceptibility in 6th through 8th grade. Students will be randomly assigned to either receive 3 anti-tobacco presentations or 3 presentations on a different topic, unrelated to tobacco.

Primary Outcome

Tobacco susceptibility captures the likelihood of using tobacco in the future. It will be assessed by likert scale questions drawn primarily from the global youth tobacco survey. It will be analyzed as a continuous variable that will be standardized, so outcomes will represent standard deviation unit differences in tobacco susceptibility.

Interventions

  • BEHAVIORAL Teens Against Tobacco Use presentation

Trial Details

FieldValue
Enrollment Target 639 participants
Start Date 2016-10
Est. Completion 2017-06
Phase NA

What the finished NCT02926339 record still lists

NCT02926339 is an interventional study that assigns participants to a tested intervention. The registered 639 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (54% lower).

The record links to 0 conditions, and to 1 intervention - of which Teens Against Tobacco Use presentation is the first listed.

NCT02926339 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02926339 about?

NCT02926339 is a clinical study titled "Teens Against Tobacco Use: A Tobacco Prevention Curriculum and Advocacy Initiative". This study evaluates the efficacy of Teens Against Tobacco Use anti-tobacco presentations on tobacco use susceptibility in 6th through 8th grade. Students will be randomly assigned to either receive 3 anti-tobacco presentations or 3 presentations on a different topic, unrelated to tobacco.

What is the current status of trial NCT02926339?

This trial is currently completed. It is a NA study. The enrollment target is 639 participants. The study started on 2016-10. Estimated completion is 2017-06.

What interventions are being tested in trial NCT02926339?

The interventions under investigation include: Teens Against Tobacco Use presentation (BEHAVIORAL).

Who is sponsoring clinical trial NCT02926339?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02926339's enrollment target sits among peer trials

639 157th of 2000 higher than 1,844 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04339699 · 640 participants · NA

    NobleStitch EL STITCH Trial is a PFO Comparative Trial

  • NCT04979338 · 640 participants · Phase 3

    Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries

  • NCT05156398 · 640 participants · Phase 3

    Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

  • NCT05930483 · 640 participants · NA

    Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02926339, the US trial registry maintained by the National Library of Medicine. NCT02926339 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.